Personalized Stem Cells focuses on harnessing the regenerative potential of mesenchymal stem cells (MSCs) derived from a patient's own adipose (fat) tissue. The company employs a meticulous process to extract and culture these stem cells, allowing them to multiply exponentially within 60 days, resulting in tens of millions of cells that are then cryopreserved for future use. This approach not only provides patients with a personalized source of stem cells but also emphasizes the therapeutic benefits of these cells, which include their ability to regenerate damaged tissues, reduce inflammation, and promote healing through the secretion of growth factors and cytokines.

The company also emphasizes the importance of bridging human and veterinary medicine through its partnership with VetStem, which has extensive experience in applying stem cell therapies in animals. This collaboration allows Personalized Stem Cells to leverage decades of veterinary data to enhance the safety and efficacy of their treatments for human patients. By utilizing insights gained from veterinary applications, the company aims to optimize treatment strategies and accelerate medical innovation, ultimately providing patients with access to advanced regenerative therapies for a variety of conditions, including osteoarthritis, heart disease, and spinal cord injuries.

United States

Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients.

Personalized Stem Cells

Company Details